Compare Nuwellis Inc (NUWE) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Verisign, Inc. — how do they compare? Nuwellis Inc trades at $1.4 (market cap $542.80K), while Verisign, Inc. trades at $284.79 (market cap $26.00B). The key difference: Verisign, Inc. is far larger — about 47899.8× Nuwellis Inc's market cap, and Verisign, Inc. pays a 1.13% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | VRSN | |
|---|---|---|
Market Cap | $542.80K | $26.00B |
Sector | Technology | Technology |
52-Week High | $220.50 | $310.00 |
52-Week Low | $1.42 | $211.49 |
Enterprise Value | -$1.27M | $27.31B |
Dividend Yield | — | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.
Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.
VeriSign (VRSN) trades at $293.34, down 0.41% with a bullish technical outlook supported by moving averages. The company reported strong Q2 2026 results with record domain registrations and 6% revenue growth, maintaining robust profit margins near 50%. Recent delegation of .web domain and AI-driven registration growth provide positive catalysts.
The stock offers 9% upside to consensus price target of $320 with 60% analyst buy ratings. Key risks include contract renewals and premium valuation at 31x P/E. Strong cash flow generation and dividend payments support shareholder returns amid stable internet infrastructure demand.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
